Brown Advisory’s Dare Bioscience DARE Stock Holding History

Brown Advisory’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-250	Closed	-$21K	–	1167
2016 Q4	$21K	Hold	250	–	–	﹤0.01%	1119
2016 Q3	$31K	Buy	+250	New	+$56K	﹤0.01%	1061

Other funds holding DARE

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Brown Advisory's DARE Position: Q1 2017 in Review

Brown Advisory sold out of Dare Bioscience (DARE) in Q1 2017, closing a stake of 250 shares — an estimated $21K sold.

Brown Advisory first reported a position in DARE in Q3 2016 and held it in 2 quarters. The position peaked at $31K in Q3 2016. 27 funds tracked by Wall St. Rank hold DARE as of Q1 2017.

Brown Advisory reported no remaining Dare Bioscience position as of Q1 2017 after selling out during the quarter.
Brown Advisory sold 250 Dare Bioscience shares in Q1 2017, an estimated $21K.
Brown Advisory first reported a position in Dare Bioscience in Q3 2016 and held it in 2 quarters.
Brown Advisory's Dare Bioscience position peaked at $31K in Q3 2016.
27 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2017.

Based on Brown Advisory's 13F filing for Q1 2017, filed 15 May 2017.